ReviewPharmaceuticals (Basel, Switzerland)2022

Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Annamaria Aprile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.